Pallade Veneta - Moderna says new booster candidate effective against Omicron subvariants

Moderna says new booster candidate effective against Omicron subvariants


Moderna says new booster candidate effective against Omicron subvariants
Moderna says new booster candidate effective against Omicron subvariants / Photo: Joseph Prezioso - AFP/File

Moderna on Wednesday said its new Covid booster candidate, which it is hoping to get approved this fall, performed well against Omicron's latest subvariants.

Change text size:

The US biotech company announced earlier this month that the so-called "bivalent" vaccine, which targets the original Covid strain and original Omicron BA.1, performed better against both compared to its original Covid vaccine called Spikevax.

In new results from a clinical study, the company said that the booster also did well against BA.4 and BA.5, Omicron's latest subvariants that are becoming dominant thanks to their increased ability to evade prior immunity, and enhanced transmissibility.

The bivalent booster elicited high levels of infection-blocking antibodies against BA.4 and BA.5 both in people who were previously infected and those not previously infected.

However even those high levels were still one third the levels achieved against the original Omicron strain, BA.1

"We will submit these data to regulators urgently and are preparing to supply our next generation bivalent booster starting in August, ahead of a potential rise in SARS-CoV-2 infections due to Omicron subvariants in the early fall," said Moderna CEO Stephane Bancel in a statement.

The BA.4 and BA.5 variants hammered South Africa, where they were first discovered, in April and May -- despite high population immunity conferred by prior waves and vaccinations.

Like other Omicron variants they tend to have a milder disease course as they settle less in the lungs and more in the upper nasal passages, causing symptoms like fever, tiredness and loss of smell.

S.Urciuoli--PV

Featured

Seacliff Healthcare Seeks Specialist GP in Thirroul

Seacliff Healthcare, located in the Illawarra region of New South Wales, is seeking a Specialist General Practitioner to join its team. The practice, situated near Thirroul village station, currently supports five GPs and has capacity for additional medical staff with onsite pathology and allied health services.

India proposes more import entry points for drugs and medical devices

New Delhi The Union Health Ministry has proposed expanding the network of authorised import gateways for drugs, medical devices and cosmetics by adding several inland container depots, a special economic zone and an international airport to facilitate faster clearance and improve supply chain efficiency. The proposed amendment to Rule 43A of the Drugs Rules, 1945, seeks to include additional entry points in Haryana, Uttar Pradesh, Gujarat, Telangana and Karnataka, as reported by a gazette notification issued by the

Why Pregnancy Cost Estimates Fail: A Family’s $9,000 Surprise

Grace Griffin thought she had calculated her pregnancy expenses accurately until bills exceeded $9,000—more than triple her insurer’s estimate. Her experience highlights a systemic failure in healthcare transparency, as federal rules designed to provide accurate cost predictions remain unimplemented. With maternity billing codes set to change next year, experts urge parents to master insurance details and verify every bill.

Kuwait inspectors destroy 115 kilograms of unverified meat in Farwaniya

KUWAIT: The Public Authority for Food and Nutrition (PAFN) issued nine violation reports and destroyed 115 kilograms of meat of unknown origin during an inspection tour of food establishments in Farwaniya Governorate, the authority announced on Monday. The tour was carried out by the authority’s Farwaniya food inspection department.

Change text size: